PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
20049873-3	2010	Recently, we demonstrated that a novel benzoxazine derivative, 6-amino-2,3-dihydro-3-hydroxymethyl-1,4-benzoxazine (ABO) could improve the proliferation of human umbilical vein endothelial cells (HUVECs) without basic fibroblast growth factor (bFGF) and serum.	6-amino-2,3-dihydro-3-hydroxymethyl-1,4-benzoxazine	63-114	fibroblast growth factor 2	Homo sapiens	212-242	
20049873-3	2010	Recently, we demonstrated that a novel benzoxazine derivative, 6-amino-2,3-dihydro-3-hydroxymethyl-1,4-benzoxazine (ABO) could improve the proliferation of human umbilical vein endothelial cells (HUVECs) without basic fibroblast growth factor (bFGF) and serum.	6-amino-2,3-dihydro-3-hydroxymethyl-1,4-benzoxazine	63-114	fibroblast growth factor 2	Homo sapiens	244-248	
20049873-3	2010	Recently, we demonstrated that a novel benzoxazine derivative, 6-amino-2,3-dihydro-3-hydroxymethyl-1,4-benzoxazine (ABO) could improve the proliferation of human umbilical vein endothelial cells (HUVECs) without basic fibroblast growth factor (bFGF) and serum.	6-amino-2,3-dihydro-3-hydroxymethyl-1,4-benzoxazine	116-119	fibroblast growth factor 2	Homo sapiens	212-242	
20049873-3	2010	Recently, we demonstrated that a novel benzoxazine derivative, 6-amino-2,3-dihydro-3-hydroxymethyl-1,4-benzoxazine (ABO) could improve the proliferation of human umbilical vein endothelial cells (HUVECs) without basic fibroblast growth factor (bFGF) and serum.	6-amino-2,3-dihydro-3-hydroxymethyl-1,4-benzoxazine	116-119	fibroblast growth factor 2	Homo sapiens	244-248